RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

I think they are setting up a deal where the terms are pre-defined, based on evidence that CX1739 reduces SA. If they show that it does, with only 20 patients, and very few with central/mixed SA, that's all they can hope for: a signal (and without dramatic adverse events). They probably have, or expect to have, the term sheets already set by that time. That does not mean it will happen, but that would be the plan. The BP people could get approval from other levels of the bureaucracy based on--IF SA OK, then.......So it doesnt have to be many months--just as they had an ADHD deal that was predicated upon being able to forward in ADHD.

Or, as I have said before, any of their assets is up for bid, and an ADHD deal could still happen.

It is also possible that R&R and the Mystery Investor may have said--if you get positive SA results, which reduces the risk, we'd be interested in another tranche, at a higher price.

NeuroInvestment